Literature DB >> 7358260

Indirect hyperbilirubinemia in HBV carriers.

K Miura, S Suzuki, S Tanaka, R Kinoshita, H Uchino, S Hirose, T Nakagawa, Y Imai.   

Abstract

Indirect hyperbilirubinemia without any other abnormalities of liver function tests was seen in 14.3% in HBV carriers and 1.2% in controls in the previous study. In order to clarify the mechanism of hyperbilirubinemia in HBV carriers, 33 HBV carriers with normal liver functions regardless of hyperbilirubinemia and with no past history of acute hepatitis were investigated clinically. Most of HBV carriers with indirect hyperbilirubinemia revealed any other abnormalities of liver functions during the over 2 years observation. Histological examinations of 4 HBV carriers with hyperbilirubinemia presented no evidence of obvious hepatitis. There was no significant correlation between bilirubin, ICG and/or BSP clearance in HBV carriers with hyperbilirubinemia. The above mentioned facts suggest that indirect hyperbilirubinemia in HBV carriers was not caused by organic changes of hepatocytes but might be the results of, at least in part, its functional disturbances. Family studies of HBV carriers with hyperbilirubinemia suggested that some but not all the HBV carriers with indirect hyperbilirubinemia might not have a genetic background in common with patients with Gilbert's syndrome. The persistent infection of HBV in hepatocytes might play an important role of metabolic derangement of bilirubin and make a constitutional defect of bilirubin metabolism manifest.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7358260     DOI: 10.1007/bf02773705

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  5 in total

1.  Normal and abnormal variations and clinical significance of the one-minute and total serum bilirubin determinations.

Authors:  L ZIEVE; E HILL; M HANSON; A B FALCONE; C J WATSON
Journal:  J Lab Clin Med       Date:  1951-09

2.  Study of the etiology and pathogenesis of low grade nonhemolytic unconjugated hyperbilirubinemia (Gilbert's disease).

Authors:  A F Blueger; E Z Krupnikova; V Y Sondore; E P Semushina
Journal:  Acta Hepatogastroenterol (Stuttg)       Date:  1977-06

3.  Cytoplasmic hepatitis B antigen in "ground-glass" hepatocytes of carriers.

Authors:  S Hadziyannis; M A Gerber; C Vissoulis; H Popper
Journal:  Arch Pathol       Date:  1973-11

4.  Idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). A study of 42 families.

Authors:  L W Powell; E Hemingway; B H Billing; S Sherlock
Journal:  N Engl J Med       Date:  1967-11-23       Impact factor: 91.245

Review 5.  Constitutional hepatic dysfunction (CHD; Gilbert's disease); a review with special reference to a characteristic increase and prolongation of the hyperbilirubinemic response to nicotinic acid.

Authors:  V L Fromke; D Miller
Journal:  Medicine (Baltimore)       Date:  1972-11       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.